ABSTRACT
F or emergency physicians working in the United
States, the evaluation of patients with nontraumatic chest pain (CP) is a daily occurrence. Data from 2014 noted there were greater than 6.9 million patients presenting to emergency departments (EDs) annually with a chief complaint of CP. 1 This number is assuredly larger today as the overall utilization of EDs increases. It follows that the use of the chest x-ray (CXR) is also increasing. Whether ordered by a physician, incorporated into triage order sets, or requested explicitly by the concerned patient, CXR has become a ubiquitous test for patients complaining of CP. With an eye toward fiscal responsibility and increased efficiency, the question arises: When is a CXR for CP unnecessary?
The utility of electrocardiogram and troponin testing in CP has previously been demonstrated in the diagnosis of acute coronary syndrome; [2] [3] [4] however, the utility of routine CXR has been less clear. 5, 6 Despite previous demonstrations of the relatively low yield of routine CXR, the American Heart Association still advocates for CXR to find alternative CP etiologies such as thoracic aortic aneurysm, pneumonia, pneumothorax, and pneumomediastinum. 7 Clinical decision rules (CDRs) have proven successful in reducing unnecessary testing in other disease states without sacrificing patient safety. 8 A well-designed and validated CDR utilizes bedside history and physical examination to guide diagnostic or therapeutic intervention. In 2002, a CDR was developed using retrospective data by Rothrock et al., 5 which included patients with any nontraumatic complaints referable to the chest (i.e., shortness of breath or CP). This study showed the CDR to have a sensitivity of 95% and a negative predictive value (NPV) of 98% for a population with a relatively high incidence of disease (17%). 5 Retrospective validation by Newsom et al. 9 at a different academic Level I trauma center found the CDR to have a sensitivity of only 79%, but because of the lower incidence of disease in this study population (5.2%), the rule maintained its NPV of 98%. This retrospective study demonstrated that a history of congestive heart failure (CHF) is one of the most influential historical items in predicting a clinically significant abnormal CXR, which is in keeping with other studies striving to determine clinical predictors of abnormal CXR in medical patients. 6, 8 In addition to a history of CHF, a history of smoking has been shown to be predictive of abnormal CXR in patients undergoing evaluation for suspected cardiac CP. 6 We sought to validate Rothrock's high-yield criteria (age ≥ 60, hemoptysis, prior/current alcohol abuse, prior tuberculosis, prior thromboembolic disease, oxygen saturation < 90%, respiratory rate > 24, temperature ≥ 100.4°F (38°C), rales, diminished breath sounds) with the addition of the two significant historical variables provided by Hess et al. 6 and Newsom et al. 9 (history of CHF and history of smoking) in a prospective multicenter study.
MATERIALS AND METHODS

Study Design
This is a prospective observational study of patients presenting to three EDs with a chief complaint of nontraumatic CP. A convenience sample of patients with nontraumatic CP were identified by research assistants or medical providers, depending on the institution. Historical and physical examination elements were provided by the physician caring for the patients. Patient charts were subsequently reviewed for CXR results per radiology read. The study protocol did not alter patient management. The research protocol was reviewed and approved by the institutional review board at each of the three study facilities, and all investigators completed mandatory research training and certification.
Study Setting and Population
The study was performed at one urban tertiary care Level I trauma center with an academic emergency medicine program, one community-based tertiary care Level I trauma center with an academic emergency medicine program, and one community-based ED. The three study sites are in three different US states. The combined volume of these three EDs is about 240,000 patient visits annually. The community academic site utilizes a nursing-driven CP pathway (which includes CXR) that allows nurses to enter orders on patients during times of high volume to facilitate department throughput. The other two sites routinely obtain CXR in patients with CP, but require a physician order to obtain CXR.
At academic sites, physicians were educated regarding the study and data collection by monthly announcements made during mandatory education time and by educational posters that were posted in prominent areas in the ED. The community ED employed research assistants who were trained by the primary investigator regarding the study and its data collection. Patients were eligible for the study if they presented to the ED with a chief complaint of nontraumatic CP and were age 18 and older. They were not excluded on the basis of multiple chief complaints (for example, CP and limb swelling or CP and shortness of breath) or as a factor of their mental status or language preference. To narrow the applicability of the decision rule to patients with nontraumatic CP, patients were excluded if they were triaged as trauma patients or if their complaint was secondary to trauma.
Study Protocol and Measurements
For the two academic sites, patients were enrolled in a convenience sample. At the community site, patients were enrolled 5 days per week, 4 hours per day as per the schedule of the research assistant. Patients eligible for this study were identified by attending physicians, resident physicians, and research assistants based on their chief complaint as entered into the electronic tracking system at each site. Providers caring for the eligible patients were approached to complete a data collection form that involved them circling any historical (hemoptysis, prior/current alcohol abuse, prior tuberculosis, prior thromboembolic disease, history of CHF, history of smoking) or physical examination items (hypoxia, tachypnea, fever, diminished breath sounds, rales) that were present. These items, along with patient age, were recorded in a standardized Excel spreadsheet by trained study personnel.
Study personnel ascertained whether a CXR was performed and recorded the results of the CXR. Staff radiologist interpretations were used as the criterion standard for defining all CXR abnormalities. The staff radiologist had access to the reason a CXR was ordered and the clinical data present in the chart at the time of CXR interpretation. In cases where the staff radiologist read was inconclusive (for example, "pneumonia versus atelectasis"), the ED diagnosis was used as the criterion standard. Abnormal CXRs were stratified a priori into those that were clinically relevant in the ED setting and those that were not. Clinically significant findings included pneumonia, pleural effusion, pneumothorax, CHF, or the presence of a new mass.
Investigators from all sites compiled data into identical data collection spreadsheets. Data was completely deidentified and pooled for analysis.
Data Analysis
Using a presumed incidence of disease of 10% and a target of 10 positive radiographs for each variable analyzed, we sought to enroll 1,100 total patients. Variables corresponding to Rothrock's CDR were analyzed for specificity and sensitivity to validate this rule. These analyses were also performed to include "history of CHF" and "history of smoking" as variables. The variables were additionally analyzed using direct logistic regression to assess their relative contributions to the rule, and odds ratios (ORs) and p-values were calculated. General demographic data and CXR results were analyzed with descriptive statistics. Data were analyzed using MedCalc (©1993-2013, Ostend, Belgium).
RESULTS
There were 1,111 patients with nontraumatic CP were enrolled over a 24-month study period from May 2013 to May 2015. Eighteen patients did not have CXR performed, and four patients had ambiguous CXR interpretations with no final diagnoses on the chart, leaving 1,089 for analysis (Figure 1 ). The median age of enrolled patients was 52 years (interquartile range = 41-64), and 588 (54%) were female.
Overall, 146 patients (13.4%) had 169 findings on CXR. Seventy-six patients (7.0%) had a total of 90 nonemergent findings, which are shown in Figure 2 . There were 70 patients (6.4%) with a total of 79 CXR findings that were determined a priori to be clinically relevant to ED care. Of the 79 clinically relevant findings, most (34, 69.8%) of these were pleural effusions followed by pneumonia (26, 43.0%) and CHF (12, 15.2%). Other findings are listed in Figure 3 .
Rothrock's high-yield criteria for CXR (any one of age ≥ 60, hemoptysis, prior/current alcohol abuse, prior tuberculosis, prior thromboembolic disease, oxygen saturation < 90%, respiratory rate > 24, temperature ≥ 100.4°F (38°C), rales, diminished breath sounds) had a sensitivity of 80.0% (confidence interval [CI] = 68.4%-88.3%) and a specificity of 56.5% (CI = 53.4%-59.6%) for detecting clinically relevant abnormalities. In this population with an overall low risk of disease, the positive predictive value was 11.2% (CI = 8.7%-14.4%) and the NPV was 97.6% (CI = 96.0%-98.6%). Including history of CHF and smoking history with Rothrock's criteria yielded a sensitivity of 92.9% (CI = 83.4%-97.3%) and a specificity of 30.4% (CI = 27.6%-33.4%), with a NPV of 98.4% (CI = 96.1%-99.4%). Applying these criteria as a CXR decision rule to this population would have reduced CXR utilization by 28.9% (n = 315), but would have resulted in five missed findings: three cases of pneumonia and two patients with pleural effusions.
The historical item most predictive of clinically relevant abnormality on CXR was CHF history. The physical examination finding most consistent with clinically relevant abnormality on CXR was hypoxia. History of tuberculosis (n = 9) and hemoptysis (n = 15) were uncommon in our population. The association of specific historical and physical examination findings with clinically relevant CXR abnormalities is shown in Table 1 .
DISCUSSION
In our multicenter, prospective study of patients presenting to the ED with nontraumatic CP, the diagnostic yield of CXR was demonstrated to be low, with 6.4% of patients having abnormalities that were thought to be clinically significant. These results fall within the range of clinically significant CXR findings that are reported in the literature, which range between 2 and 25% prevalence of abnormal CXRs. 5, 6, [9] [10] [11] [12] [13] [14] [15] Interestingly, older studies 14, 15 in the literature from the 1980s and 1990s tended to have higher incidences of abnormal CXR, perhaps due to a more selective use of CXR ordering criteria or more liberal criteria as to what constituted a significant abnormality. This is in contrast to the study by Hess et al., 6 which used a fairly narrow definition of what was considered a clinically significant abnormality and found an incidence of disease of 2.1%. An ideal decision rule would have a high sensitivity without compromising specificity, allowing a reduction in testing while preserving patient safety. Application of the criteria previously described by Rothrock et al. 5 in this patient population would result in a sensitivity of 80.0% (95% CI = 64.4%-88.3%), which is lower than the 95% (95% CI = 92%-98%) sensitivity reported in the original derivation set and similar to the sensitivity of 79% (95% CI = 64%-89%) obtained in another study attempting to validate Rothrock criteria for CXR ordering. 9 When applied to a population with a low incidence of disease, the NPV remains high, with a NPV of 98% in the current population as well as in the study by Newsom et al. 9 Use of a combination of the original criteria described by Rothrock with two additional criteria described by Hess (smoking and history of CHF) resulted in a higher sensitivity (92.9%, 95% CI = 83.4%-97.3%), with a slight decrease in specificity to 30.4% (95% CI 27.6-33.4%). In our population with a prevalence of abnormal x-rays of 6%, this rule produced an adequate NPV (98.4%, 95% CI = 96.1%-99.4%) to suggest clinical utility. However, if this rule was applied to a population with a higher prevalence of disease, such as the 17% prevalence described by Rothrock, the NPV would fall to 95%. As with other CDRs, knowledge of the prevalence of disease in the population is important prior to application of the rule. Data from the derivations and validations of the three CXR decision rules are summarized in Table 2 .
Although the specificity of the adapted decision rule is only modest, the frequency of CP presentations means that even small percentage decreases in CXR utilization could result in large decreases in absolute numbers of CXR performed. Assuming a Medicare National Payment Amount 16 of $28.35 for a two-view CXR applied to the 6.8 million annual U.S. visits for CP, a 29% reduction in CXR due to the application of the refined Rothrock criteria would potentially result in a savings of $58 million.
Although some might argue that a CDR containing 10 elements might be too cumbersome for use, it is no more complex than the Wells criteria for pulmonary embolism followed by the Pulmonary Embolism Rule-out Criteria (PERC) or the HEART score for acute cardiac ischemia. In addition, the modified CDR could be incorporated into electronic ordering of CXRs for patients with a chief complaint of CP, reducing the need for physicians or other providers to remember the rule and apply it to each patient.
LIMITATIONS
Patient enrollment by convenience sample, rather than continuous consecutive enrollment, raises the potential for enrollment bias, particularly in sites without research assistants whose primary responsibility was to enroll patients with CP. This could have resulted in preferential enrollment of patients during times of lower ED volume or during certain times of the day, resulting in a skewed population of patients enrolled in comparison to those not enrolled. It is also possible that awareness of the ongoing study impacted the physicians' rate of CXR ordering.
Data were not collected on the number of CP patients who were eligible but not enrolled during data collection. Therefore, it is difficult to know whether the patients enrolled were truly representative of CP patient population on the whole. Our incidence of disease, while similar to other studies, was relatively low, and therefore these criteria should be used with caution in populations with a known higher incidence of disease. Although all participating ED physicians were residency trained and board certified in emergency medicine, practice patterns can vary significantly by provider, which could lead to differences in patient identification for eligibility and evaluation. Also, patient identification of eligibility by chief complaint is limited by the method in which the chief complaint is imported into the computerized tracking system: that data may be imported by a triage nurse, a registration clerk, or a physician, depending on time of day, patient mode of arrival, and triage system. Similarly, data collected at sites using triage nursing order sets may have been impacted by protocol-based ordering by a nonphysician.
As with any research including historical factors derived from patient interview, certain elements may be inaccurate or intentionally suppressed, particularly those with an attached social stigma (i.e., alcoholism and smoking history). We attempted to reduce the impact of incomplete charting by collecting data in real time, but the complete accuracy of the history provided by patients cannot be guaranteed. In addition, the physical examination elements utilized (rales, diminished breath sounds) may have poor inter-observer reliability, limiting the usefulness of the tool. There were a small number of patients who did not have a CXR performed or did not have diagnoses on their charts, who were not included in analysis. Since we did not have other follow-up with these patients, it is unclear whether their results would be similar to the rest of our cohort. Finally, it is important to remember that, Sig. abnormality = 17% Sensitivity = 95% (CI = 92%-98%) Specificity = 40% (CI = 37%-43%) PPV = 25% (CI = 23%-27%) NPV = 98% (CI = 96%-99%)
Newsome et al. 9 n = 967 Sig. abnormality = 5.1% Sensitivity = 79% (CI = 64%-89%) Specificity = 59% (CI = 55%-62%) PPV = 9% (CI = 6%-12%) NPV = 98% (CI = 97%-99%) Current study n = 1,089 Sig abnormality = 6.4% Sensitivity = 80% (CI = 68%-88%) Specificity = 57% (CI = 53%-60%) PPV = 11% (CI = 9%-14%) NPV = 98% (CI = 96%-99%)
Hess criteria Smoking CHF Auscultory lung abnormality
Hess et al. 6 n = 529 Sig. abnormality = 2.1% Sensitivity = 100% (CI = 72%-100%) Specificity = 36% (CI = 32%-40%)
Goldschlager et al. 10 n = 760 Sig. abnormality = 12% Sensitivity = 80% (CI = 70%-87%) Specificity = 50% (CI = 47%-54%) PPV = 18% (CI = 15%-22%) NPV = 95% (CI = 92%-97%) Poku et al. 13 n = 1,159 Sig. abnormality = 6% Sensitivity = 78% (CI = 67%-86%) Specificity = 45% (CI = 42%-48%) PPV = 7% (CI = 5%-8%) NPV = 100% (CI = 96%-100%) n = 967 Sig. abnormality = 5.1% Sensitivity = 79% (CI = 64%-89%) Specificity = 69% (CI = 66%-72%) PPV = 11% (CI = 8%-16%) NPV = 98% (CI = 97%-99%) Current study n = 1,089 Sig. abnormality = 6.4% Sensitivity = 93% (CI = 83%-97%) Specificity = 30% (CI = 28%-33%) PPV NPV = 98% (CI = 96%-99%) CHF = congestive heart failure; CXR = chest x-ray; DVT = deep vein thrombosis; NPV = negative predictive value; PE = pulmonary embolism; PPV = positive predictive value.
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CONCLUSION
This prospective validation and refinement of a decision rule for the performance of chest x-ray in patients presenting to the ED with nontraumatic chest pain demonstrated adequate sensitivity and high negative predictive value, suggesting that it can be safely applied in populations with low incidence of disease. Application may result in a significant reduction in chest x-ray utilization and cost savings. Additional studies should be done to further validate this refined decision rule to demonstrate its efficacy and safety prior to implementation in clinical practice.
